Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Milestone Pharmaceuticals Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +19 vs. Q2 2022
- Shares held
- 22.0M
- +1.15M (+5.5%) vs. Q2 2022
- Total value
- $198.7M
- +$71.5M (+56.2%) vs. Q2 2022
- New holders
- 21
- 9 more added
- Sold out
- 2
- 12 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 4,315,102 | $39.7M | 0.91% | 00.0% | Unchanged |
| VR Adviser, LLC | 2,425,737 | $22.3M | 3.44% | +2,425,737 | New |
| Ra Capital Management, L.P. | 2,246,503 | $20.6M | 0.44% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,000,000 | $18.4M | 0.88% | −530,003−20.9% | Reduced |
| Morgan Stanley | 1,240,273 | $11.4M | 0.00% | −77,900−5.9% | Reduced |
| Lion Point Capital, LP | 1,557,233 | $11.2M | 4.52% | +608,663+64.2% | Added |
| Millennium Management LLC | 933,098 | $8.57M | 0.01% | −425,264−31.3% | Reduced |
| Ikarian Capital, LLC | 855,616 | $7.86M | 3.92% | −523,806−38.0% | Reduced |
| Boxer Capital, LLC | 698,861 | $6.42M | 0.36% | −1,540,000−68.8% | Reduced |
| Great Point Partners LLC | 674,656 | $6.20M | 1.49% | +674,656 | New |
| Paradigm Biocapital Advisors LP | 634,211 | $5.83M | 0.82% | +634,211 | New |
| Acuta Capital Partners, LLC | 597,026 | $5.49M | 2.44% | +139,826+30.6% | Added |
| Citadel Advisors LLC | 596,978 | $5.49M | 0.01% | +596,978 | New |
| Pura Vida Investments, LLC | 596,531 | $5.48M | 0.83% | −390,880−39.6% | Reduced |
| Janus Henderson Group PLC | 560,168 | $5.14M | 0.00% | +560,168 | New |
| Barclays PLC | 540,582 | $4.97M | 0.01% | +328,872+155.3% | Added |
| Bleichroeder LP | 512,500 | $4.71M | 0.98% | 00.0% | Unchanged |
| Eversept Partners, LP | 126,826 | $1.17M | 0.14% | −20,339−13.8% | Reduced |
| Goldman Sachs Group Inc | 104,497 | $960.0K | 0.00% | +92,493+770.5% | Added |
| Valeo Financial Advisors, LLC | 75,500 | $694.0K | 0.04% | +75,500 | New |
| Boothbay Fund Management, LLC | 73,752 | $678.0K | 0.02% | −58,749−44.3% | Reduced |
| Dimensional Fund Advisors LP | 73,274 | $673.0K | 0.00% | −2,072−2.7% | Reduced |
| Bank of America Corp | 72,680 | $668.0K | 0.00% | +72,680 | New |
| Ensign Peak Advisors, Inc | 69,422 | $638.0K | 0.00% | +69,422 | New |
| JPMorgan Chase & Co | 53,675 | $493.0K | 0.00% | +50,136+1,416.7% | Added |
| Bank of Montreal | 48,100 | $446.0K | 0.00% | +48,100 | New |
| Susquehanna International Group, LLP | 46,308 | $426.0K | 0.00% | +28,075+154.0% | Added |
| LMR Partners LLP | 38,495 | $354.0K | 0.01% | +26,763+228.1% | Added |
| Marshall Wace, LLP | 30,898 | $284.0K | 0.00% | +30,898 | New |
| Fred Alger Management, LLC | 26,672 | $245.0K | 0.00% | +26,672 | New |
| Caption Management, LLC | 25,378 | $233.0K | 0.04% | +25,378 | New |
| State Street Corp | 21,996 | $202.0K | 0.00% | +388+1.8% | Added |
| Geode Capital Management, LLC | 17,576 | $161.0K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 11,800 | $108.0K | 0.01% | +11,800 | New |
| Cubist Systematic Strategies, LLC | 11,600 | $107.0K | 0.00% | +11,600 | New |
| Susquehanna Fundamental Investments, LLC | 11,499 | $106.0K | 0.00% | +11,499 | New |
| Federation des caisses Desjardins du Quebec | 10,500 | $96.5K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 4,248 | $39.0K | 0.00% | +4,248 | New |
| Cutler Group LP | 3,937 | $36.0K | 0.00% | +3,937 | New |
| UBS Group AG | 3,320 | $31.0K | 0.00% | +2,304+226.8% | Added |
| National Bank of Canada | 2,880 | $26.0K | 0.00% | −11,962−80.6% | Reduced |
| Advisor Group Holdings, Inc. | 2,602 | $24.0K | 0.00% | −277−9.6% | Reduced |
| Cowen and Company, LLC | 14,000 | $20.0K | 0.00% | +14,000 | New |
| Royal Bank of Canada | 2,000 | $18.0K | 0.00% | −16,500−89.2% | Reduced |
| CSS LLC | 1,008 | $9.00K | 0.00% | +1,008 | New |
| The PNC Financial Services Group, Inc. | 137 | $1.00K | 0.00% | +137 | New |
| BlackRock Inc. | 5 | $0 | 0.00% | +5 | New |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,817,521−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −13,717−100.0% | Sold out |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |